← FDA DRUG APPROVALS

FDA ANDA · ANDA201451

MECLIZINE HYDROCHLORIDE

meclizine

Sponsor: AMNEAL PHARMS

APPLICATION
ANDA201451
TYPE
ANDA
ORIGINAL APPROVAL
2011-02-23
LATEST ACTION
2023-09-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MECLIZINE HYDROCHLORIDEPrescription
MECLIZINE HYDROCHLORIDE 12.5MG · TABLET · ORAL
MECLIZINE HYDROCHLORIDEPrescription
MECLIZINE HYDROCHLORIDE 25MG · TABLET · ORAL
MECLIZINE HYDROCHLORIDEPrescription
MECLIZINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2023-09-22Labeling · Supplement 7 · standardAP
2023-09-22Labeling · Supplement 8 · standardAP
2023-09-22Labeling · Supplement 6 · standardAP
2013-08-15Labeling · Supplement 2 · standardAP
2011-02-23Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →